Spnib (Dasatinib 70 mg) x 60 Tablets

Uses of DASATINIB 70 mg

• Treats chronic myeloid leukemia (CML).
• Used for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
• Helps control resistant or newly diagnosed CML.
• Reduces abnormal white blood cell growth.
• Used when other targeted therapies are not suitable or effective.

Benefits of DASATINIB 70 mg

• Specifically targets leukemia cells.
• Slows cancer cell growth and spread.
• Helps reduce abnormal blood counts.
• May improve survival outcomes.
• Supports long-term disease control.
• Convenient once-daily oral tablet.
• May reduce the need for intensive chemotherapy.
• Effective in resistant cases.
• Helps improve quality of life.
• Provides targeted cancer therapy.

How Does It Work?

Dasatinib is a tyrosine kinase inhibitor (TKI) that blocks the abnormal BCR-ABL protein, which drives the uncontrolled growth of leukemia cells. By inhibiting this protein, it stops cancer cell signaling, slowing or preventing disease progression.

Precautions

• Take exactly as prescribed by your doctor.
• Swallow tablet whole with water.
• Regular blood tests are required.
• Inform your doctor if you have heart, liver, or bleeding problems.
• Report fever, infection, or unusual bleeding immediately.
• Avoid grapefruit products.
• Use effective contraception during treatment.
• Do not breastfeed while on treatment.
• Inform doctor about all medicines and supplements.
• Do not stop medication without medical advice.

Side Effects

• Headache and dizziness
• Nausea, vomiting, or diarrhea
• Fluid retention (swelling around eyes, hands, or feet)
• Low blood cell counts (anemia, neutropenia, thrombocytopenia)
• Fatigue or weakness

Buy Spnib Dasatinib 70 mg Tablets in bulk at competitive prices

Buy Spnib Dasatinib 70 mg Tablets from our trusted and licensed international pharmacy. We supply authentic generic anticancer medications in bulk to patients, hospitals, doctors, clinics, and healthcare professionals across many countries, including Colombia, Peru, the Philippines, Venezuela, Panama, Ecuador, Namibia, South Africa, Zimbabwe, Bahrain, Cyprus, Egypt, Iran, Iraq, Israel, Jordan, Palestine, Qatar, Saudi Arabia, the United Arab Emirates, China, Canada, Brazil, Mexico, Russia, Thailand, Malaysia, Singapore, Vietnam, South Korea, Taiwan, Indonesia, the United States, and more.